SEC Company Response from Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704) (CLRB) — Jul 25, 2018
Cellectar Biosciences, Inc. (CLRB) (CIK 0001279704)
Date: July 25, 2018 · CIK: 0001279704 · Accession: 0001144204-18-039887
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-225675
Letter
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
July 25, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Suzanne Hayes, Assistant Director
Re: Cellectar Biosciences, Inc.
Registration Statement on Form S-1
File No. 333-225675
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-225675), as amended, be accelerated so that the Registration Statement will become effective at 4:15 p.m. on July 26, 2018, or as soon as practicable thereafter.
The cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact Gregory J. Lynch of Michael Best & Friedrich LLP at (608) 283-2240 or gjlynch@michaelbest.com or Joshua B. Erekson of Michael Best & Friedrich LLP at (801) 833-0505 or jberekson@michaelbest.com. Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CELLECTAR BIOSCIENCES, INC.
3301 Agriculture Drive
Madison, WI 53716
July 25, 2018
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Suzanne Hayes, Assistant Director
Re:
Cellectar Biosciences, Inc.
Registration Statement on Form S-1
File No. 333-225675
Ladies and Gentlemen:
Pursuant to Rule 461(a) under the Securities
Act of 1933, as amended, Cellectar Biosciences, Inc., a Delaware corporation (the “Company”), hereby requests that
the effective date of the Company’s Registration Statement on Form S-1 (Registration No. 333-225675), as amended, be accelerated
so that the Registration Statement will become effective at 4:15 p.m. on July 26, 2018, or as soon as practicable thereafter.
The
cooperation of the staff in meeting our request is very much appreciated. If you have any questions or comments, please contact
Gregory J. Lynch of Michael Best & Friedrich LLP at (608) 283-2240 or
gjlynch@michaelbest.com or Joshua B. Erekson of Michael Best & Friedrich LLP at (801) 833-0505 or jberekson@michaelbest.com.
Thank you for your assistance with these matters.
Very truly yours,
CELLECTAR BIOSCIENCES, INC.
By:
/s/ Brian Posner
Brian Posner, Vice President and Chief Financial Officer
cc:
James V. Caruso
Gregory J. Lynch
Joshua B. Erekson